GILD

Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
$130.04
-1.36 (-1.04%)
Mkt Cap: 161.45B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield6.2%
Dividend YieldN/A
Market Cap161.45B
Volume5.26M
Recent News
Congo begins trial of Gilead's experimental antiviral for Ebola Bundibugyo
reuters.com · 2026-07-14
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
fool.com · 2026-07-12
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
zacks.com · 2026-07-10
2 Recession-Resistant Dividend Stocks to Buy and Hold
fool.com · 2026-07-10
A Look at Gilead Sciences Inc (GILD) After 5.2% Gain -- GF Value $96.06 vs Price $136.36
gurufocus.com · 2026-07-07
Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”
247wallst.com · 2026-07-07

Unlock the Full Deep Scan

9 AI agents analyze GILD across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →